tradingkey.logo
tradingkey.logo
Suchen

Smith & Nephew PLC

SNN
Zur Watchlist hinzufügen
30.290USD
+0.250+0.83%
Handelsschluss 06/29, 16:00ETKurse um 15 Minuten verzögert
12.81BMarktkapitalisierung
26.95KGV TTM

mehr Informationen über Smith & Nephew PLC Unternehmen

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Smith & Nephew PLC Informationen

BörsenkürzelSNN
Name des UnternehmensSmith & Nephew PLC
IPO-datumSep 18, 2087
CEONath (Deepak S)
Anzahl der mitarbeiter17349
WertpapierartDepository Receipt
GeschäftsjahresendeSep 18
AddresseBuilding 5
StadtWATFORD
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited Kingdom
PostleitzahlWD18 8YE
Telefon4401923477100
Websitehttps://www.smith-nephew.com/
BörsenkürzelSNN
IPO-datumSep 18, 2087
CEONath (Deepak S)

Führungskräfte von Smith & Nephew PLC

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.41K
+2.16%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.40K
+2.17%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+22.23%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.29K
+1.70%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.19K
+4.86%
Mr. Craig Gaffin
Mr. Craig Gaffin
President - Orthopaedics
President - Orthopaedics
894.00
+2.57%
Ms. Elga Lohler
Ms. Elga Lohler
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.41K
+2.16%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.40K
+2.17%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+22.23%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Smith & Nephew PLC?

Die fünf größten Anteilseigner von Smith & Nephew PLC sind: Dr. Ajay Dhankhar, Ph.D.

Wie viele Institutionen halten Anteile an Smith & Nephew PLC (SNN)?

Mit Stand vom 2026Q1 halten 471 Institutionen Anteile an Smith & Nephew PLC, mit einem Gesamtmarktwert von etwa 30.95M, was 7.25% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -11491314.00 gestiegen.

Was ist die größte Einnahmequelle von Smith & Nephew PLC?

Am 2026Q1 erzielte das Geschäft mit Sports Medicine Joint Repair für Smith & Nephew PLC den höchsten Umsatz in Höhe von 1.07B, was 17.31% des Gesamtumsatzes entspricht.
KeyAI